Podcasts & Media

In this episode Ryan interviews Dr. Alex Krotulski PhD from the Center for Forensic Science Research and Education. Together take a look at trends in novel opioids, benzodiazepines, stimulants, hallucinogens, synthetic cannabinoids, and "hemp products" that are showing up in your patients, drug products, and fatal overdoses. The conversation takes places around the Center for Forensic Science Research and Education quarterly report on Novel Psychoactive Substances found in patients and drug products.

The episode starts with a discussion of the novel benzodiazepines market, highlighting bromazolam and how long it may remain in the market. Then they discuss the opioids highlighting where we are seeing carfentanil, what is happening with Para Fluorofentanyl, and other super potent opioids emergening (such as N -pyrrolidino etonitazene). After a quick discussion of synthetic cathinone's and PCP/ketamine derivatives they jump to synthetic cannabinoids.
LISTEN NOW

Keeping up to date with New Psychoactive Substances is hard! We've assembled a crack team of experts to help us do just that: Michael Evans-Brown from EMCDDA, Conor Crean from UNODC, and Alex Krotulski from CFSRE.

These updates will be a regular part of our podcast schedule, letting you know about recent developments in NPS markets, detection and harms. In this episode we discuss an increasing trend of xylazine in fentanyl supplies, the recent scheduling of some NPS by the United Nations, and the emergence of semi-synthetic cannabinoids including HHC.
LISTEN NOW

More than 100,000 Americans died of a drug overdose in 2021, the worst year on record. The newest wave of the overdose crisis involves man-made chemicals, including animal tranquilizers, that are being combined with fentanyl to make street drugs that are deadlier and more addictive.

With access to an undisguised fentanyl dealer, Beyond Fentanyl looks at how drugs like “benzo dope” and “tranq” are ravaging North American communities and how U.S. policy affected the latest flood of synthetic street drugs.
Watch Now

Keeping up to date with New Psychoactive Substances is hard! We've assembled a crack team of experts to help us do just that: Michael Evans-Brown from EMCDDA, Conor Crean from UNODC, and Alex Krotulski CFSRE and NPS Discovery.

These updates will be a regular part of our podcast schedule, letting you know about recent developments in NPS markets, detection and harms. In this episode we discuss cathinones, the recent contamination of synthetic cannabinoids with brodifacoum, and the future of psychedelics.
LISTEN NOW

Keeping up to date with New Psychoactive Substances is hard! We've assembled a crack team of experts to help us do just that: Michael Evans-Brown from EMCDDA, Conor Crean from UNODC, and Alex Krotulski CFSRE and NPS Discovery.
Listen Now

“New Psychoactive Substances with Alex Krotulski” comes from the ToxPod with Tim Scott and Peter Stockham discussing NPS and expanding world of NPS Discovery.
Listen Now

“Street Sampling Synthetics, from Carfentanil to Xylazine with Alex Krotulski” comes from Narcotica focusing on drug trends, combinations, and much more.
Listen Now

CFSRE’s Mandi Mohr and Alex Krotulski comes from RTI and NIJ’s Forensic Technology Center of Excellence [FTCoE, Award 2016-MU-BX-K110] to discuss the analytical and interpretative challenges associated with emerging drug threats and NPS.